Abstract：
:Targeted protein degradation is an emerging technology for drug development. An article published in Nature reported a novel mechanism of targeted protein degradation triggered by small-molecule-induced polymerization of the oncogenic transcription factor BCL6.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Naito M,Murata Sdoi
10.1016/j.ccell.2020.12.020subject
Has Abstractpub_date
2021-01-11 00:00:00pages
19-21issue
1eissn
1535-6108issn
1878-3686pii
S1535-6108(20)30668-1journal_volume
39pub_type
杂志文章相关文献
CANCER CELL文献大全abstract：:CAR-engineered T cell immunotherapy has proven transformative in selected hematological malignancies. However, solid tumors largely remain impervious to these approaches. In addressing this challenge, Srivastava et al. in this issue demonstrate that oxaliplatin-based lymphodepleting chemotherapy promotes enhanced CAR ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.12.019
更新日期：2020-12-30 00:00:00
abstract：:Homeotic (HOX) genes are dysregulated in multiple malignancies, including several AML subtypes. We demonstrate that H3K79 dimethylation (H3K79me2) is converted to monomethylation (H3K79me1) at HOX loci as hematopoietic cells mature, thus coinciding with a decrease in HOX gene expression. We show that H3K79 methyltrans...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2014.10.009
更新日期：2014-12-08 00:00:00
abstract：:Current strategies combining anti-angiogenic drugs with chemotherapy provide clinical benefit in cancer patients. It is assumed that anti-angiogenic drugs, such as bevacizumab, transiently normalize abnormal tumor vasculature and contribute to improved delivery of subsequent chemotherapy. To investigate this concept, ...
journal_title：Cancer cell
pub_type： 临床试验,杂志文章
doi：10.1016/j.ccr.2011.11.023
更新日期：2012-01-17 00:00:00
abstract：:The E2F family of transcription factors is critical for the control of cell cycle progression. We now show that the specific inactivation of E2F3 in mouse embryo fibroblasts (MEFs) results in a disruption of the centrosome duplication cycle. Loss of E2F3, but not E2F1, E2F2, E2F4, or E2F5 results in unregulated cyclin...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(03)00083-7
更新日期：2003-04-01 00:00:00
abstract：:Immune checkpoint blockade therapies fail to induce responses in the majority of cancer patients, so how to increase the objective response rate becomes an urgent challenge. Here, we demonstrate that sufficient T cell infiltration in tumor tissues is a prerequisite for response to PD-L1 blockade. Targeting tumors with...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.02.004
更新日期：2016-03-14 00:00:00
abstract：:Breast cancer is a heterogeneous disease and can be classified based on gene expression profiles that reflect distinct epithelial subtypes. We identify prostate-derived ETS factor (PDEF) as a mediator of mammary luminal epithelial lineage-specific gene expression and as a factor required for tumorigenesis in a subset ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.04.026
更新日期：2013-06-10 00:00:00
abstract：:We investigated the transcriptional and epigenetic repression of miR-29 by MYC, HDAC3, and EZH2 in mantle cell lymphoma and other MYC-associated lymphomas. We demonstrate that miR-29 is repressed by MYC through a corepressor complex with HDAC3 and EZH2. MYC contributes to EZH2 upregulation via repression of the EZH2 t...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2012.09.003
更新日期：2012-10-16 00:00:00
abstract：:The EZH2 histone methyltransferase mediates the humoral immune response and drives lymphomagenesis through formation of bivalent chromatin domains at critical germinal center (GC) B cell promoters. Herein we show that the actions of EZH2 in driving GC formation and lymphoma precursor lesions require site-specific bind...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.07.006
更新日期：2016-08-08 00:00:00
abstract：:Cancer cells reprogram their metabolism using different strategies to meet energy and anabolic demands to maintain growth and survival. Understanding the molecular and genetic determinants of these metabolic programs is critical to successfully exploit them for therapy. Here, we report that the oncogenic melanocyte li...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2012.11.020
更新日期：2013-03-18 00:00:00
abstract：:Tumorigenesis is often associated with an unbalanced protein homeostasis (proteostasis) network, which sensitizes cancer cells to drugs targeting protein quality control (PQC) regulators. In this issue of Cancer Cell, Anderson and colleagues investigated the anti-cancer activity of a new class of inhibitor against a m...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2015.10.006
更新日期：2015-11-09 00:00:00
abstract：:MYC is an oncogenic driver that regulates transcriptional activation and repression. Surprisingly, mechanisms by which MYC promotes malignant transformation remain unclear. We demonstrate that MYC interacts with the G9a H3K9-methyltransferase complex to control transcriptional repression. Inhibiting G9a hinders MYC ch...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2018.09.001
更新日期：2018-10-08 00:00:00
abstract：:One of the biggest challenges in treating acute myeloid leukemia (AML) is relapse of aggressive disease after treatment. In this issue of Cancer Cell, Boyd et al. characterize a molecularly distinct population of chemotherapy-induced transient leukemic regenerating cells (LRCs), which can be exploited to prevent AML r...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.08.012
更新日期：2018-09-10 00:00:00
abstract：:Besides their function in limiting blood loss and promoting wound healing, experimental evidence has highlighted platelets as active players in all steps of tumorigenesis including tumor growth, tumor cell extravasation, and metastasis. Additionally, thrombocytosis in cancer patients is associated with adverse patient...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2018.03.002
更新日期：2018-06-11 00:00:00
abstract：:Metastases arising from tumors have the proclivity to colonize specific organs, suggesting that they must rewire their biology to meet the demands of the organ colonized, thus altering their primary properties. Each metastatic site presents distinct metabolic challenges to a colonizing cancer cell, ranging from fuel a...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2018.02.001
更新日期：2018-03-12 00:00:00
abstract：:Abnormal activation of the epidermal growth factor receptor (EGFR) and its homolog HER2 (Neu/ErbB2) has been associated with many human cancers, and monoclonal antibodies targeting EGFR and HER2 are effective anticancer therapies. Structural studies of these receptors and antibodies have revealed much about how they f...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2008.03.010
更新日期：2008-04-01 00:00:00
abstract：:Activating mutations in BRAF are the most common genetic alterations in melanoma. Inhibition of BRAF by small molecules leads to cell-cycle arrest and apoptosis. We show here that BRAF inhibition also induces an oxidative phosphorylation gene program, mitochondrial biogenesis, and the increased expression of the mitoc...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.02.003
更新日期：2013-03-18 00:00:00
abstract：:Numerous lines of investigation suggest that nuclear factor NF-kappaB, a proinflammatory transcription factor, could promote tumorigenesis. Various inflammatory agents, carcinogens, tumor promoters, and the tumor microenvironment activate NF-kappaB. NF-kappaB proteins themselves and proteins regulated by it have been ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccr.2004.09.003
更新日期：2004-09-01 00:00:00
abstract：:Recent evidence suggests that human cells require more genetic changes for neoplastic transformation than do their murine counterparts. However, a precise enumeration of these differences has never been undertaken. We have determined that perturbation of two signaling pathways-involving p53 and Raf-suffices for the tu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.07.009
更新日期：2004-08-01 00:00:00
abstract：:Tumors are influenced by the mechanical properties of their microenvironment. Using patient samples and atomic force microscopy, we found that tissue stiffness is higher in liver metastases than in primary colorectal tumors. Highly activated metastasis-associated fibroblasts increase tissue stiffness, which enhances a...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.05.005
更新日期：2020-06-08 00:00:00
abstract：:Angiogenesis is a hallmark of solid tumors, and disruption of tumor vasculature is an active anticancer therapy in some cases. Several proteins expressed on the surface of tumor endothelium have been identified during the last decade. However, due to the expression in both physiological and tumor angiogenesis, only a ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2007.05.004
更新日期：2007-06-01 00:00:00
abstract：:To identify FDA-approved agents targeting leukemic cells, we performed a chemical screen on two human leukemic cell lines and identified the antimicrobial tigecycline. A genome-wide screen in yeast identified mitochondrial translation inhibition as the mechanism of tigecycline-mediated lethality. Tigecycline selective...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.10.015
更新日期：2011-11-15 00:00:00
abstract：:Genome-wide cancer mutation analyses are revealing an extensive landscape of functional mutations within the noncoding genome, with profound effects on the expression of long noncoding RNAs (lncRNAs). While the exquisite regulation of lncRNA transcription can provide signals of malignant transformation, we now underst...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2016.03.010
更新日期：2016-04-11 00:00:00
abstract：:Adaptive chemoresistance and consequent tumor recurrence present major obstacles to the improvement of the prognosis and quality-of-life of patients with advanced-stage ovarian cancer. In this issue of Cancer Cell, Yu and colleagues describe the critical role of spleen tyrosine kinase (SYK) in paclitaxel resistance by...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2015.06.008
更新日期：2015-07-13 00:00:00
abstract：:Here, we show that tumor ADORA1 deletion suppresses cell growth in human melanoma cell lines in vitro and tumor development in vivo in immune-deficient xenografts. However, this deletion induces the upregulation of PD-L1 levels, which inactivates cocultured T cells in vitro, compromises anti-tumor immunity in vivo, an...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.02.006
更新日期：2020-03-16 00:00:00
abstract：:In this issue of Cancer Cell, demonstrate a novel mechanism for the oncogenic activity of MLL chimeric proteins. By providing coiled-coil or other dimerization domains, the cytoplasmic partners of MLL fusion proteins donate a platform for MLL homodimerization, allowing recruitment of accessory factors needed to activa...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/s1535-6108(03)00192-2
更新日期：2003-08-01 00:00:00
abstract：:Perturbation biology is a powerful approach to modeling quantitative cellular behaviors and understanding detailed disease mechanisms. However, large-scale protein response resources of cancer cell lines to perturbations are not available, resulting in a critical knowledge gap. Here we generated and compiled perturbed...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.10.008
更新日期：2020-12-14 00:00:00
abstract：:Constitutive activation of NF-κB signaling can promote oncogenesis, providing a rationale for anticancer strategies that inhibit NF-κB signaling. Two recent publications in Genes & Development provide evidence that, in contexts where prosurvival signals derive from other oncogenes, NF-κB activity instead enhances sens...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2011.10.026
更新日期：2011-11-15 00:00:00
abstract：:In this issue of Cancer Cell, Gruber et al. report that a significant proportion of children with acute megakaryoblastic leukemia acquire a translocation that confers enhanced BMP signaling and promotes self-renewal of hematopoietic progenitors. This study presents novel therapeutic targets that may lead to improved t...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2012.10.008
更新日期：2012-11-13 00:00:00
abstract：:Cancer-associated chromosomal translocations create chimeric oncoproteins that contribute to aberrant growth by dominant or dominant negative mechanisms. Interestingly, genes such as MLL, RARA, and EWS are fused to multiple partners. This molecular promiscuity can provide important functional information, as specific ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(04)00060-1
更新日期：2004-03-01 00:00:00
abstract：:Women with ErbB2-positive breast cancer have a poor prognosis, and frequently, chemotherapy treatment is ineffective. The ErbB2-targeted antibody trastuzumab improves survival when given with chemotherapy to patients with ErbB2-overexpressing metastatic disease, but treatment is not curative, and primary resistance is...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2004.08.001
更新日期：2004-08-01 00:00:00
